Searched for
GENERIC RHINITIS DRUG
These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Sun Pharma recalls over 1.10 lakh bottles of generic drug in US marketThe company is recalling 73,957 bottles of 5 mg strength and 36,786 bottles of 20 mg strength, the US health regulator stated. An affected ...
- Sun Pharma, Lupin recall products in US marketAccording to USFDA, the Mumbai-based drug maker is recalling the affected lot due to "failed moisture limits."
- Glenmark Pharma launches nasal spray Ryaltris in IndiaGlenmark being one of the leaders in respiratory segment, has been the first to launch the branded generic version at an affordable cost fo...
- JB Chemicals gets USFDA nod for generic productThe US Food and Drug Administration (USFDA) has approved company's abbreviated new drug application (ANDA) for Loratadine tablets USP 10 mg...
- Strides gets USFDA nod for anti-allergic drugThe company said, it is focusing on building a private label business in the US by leveraging its portfolio of products across softgels, ta...
- Unichem Labs gets USFDA nod for asthma drugThe tablets are indicated for prophylaxis and chronic treatment of asthma in adults and pediatric patients - 12 months of age and older.
- Glenmark readies specialty, innovative pipeline as pricing challenges loom in the USGlenmark’s consolidated net profit saw a deep cut, dropping 78 per cent to Rs. 104.7 crore.
- Ajanta Pharma launches generic asthma treatment tablets in USAjanta Pharma has launched its generic Montelukast Sodium tablets used for treatment of asthma and seasonal allergies in the American marke...
- Unichem gets USFDA nod for generic asthma treatment tabletsDrug firm Unichem Laboratories has received approval from the US health regulator for its Montelukast Sodium tablets used in prevention and...
- Aurobindo Pharma, Glenmark get FDA nod for generic montelukast sodium tabletsNew Delhi Drug firms Aurobindo Pharma and Glenmark have received approval from the US health regulator to manufacture and market generic mo...
- Aurobindo Pharma, Glenmark get USFDA nod for generic asthma drugAurobindo, Glenmark today said they have received approval from the US health regulator to manufacture, market generic montelukast tablets.
- Sun Pharmaceutical gets USFDA nod for nasal spray AstelinSun Pharmaceutical Industries has received approval from the US health regulator to sell its generic version of Astelin, used in treating n...
- Wockhardt receives USFDA approval for Fluticasone nasal sprayWockhardt received final approval from the USFDA to market generic Fluticasone nasal spray, used for treating allergic nasal inflammation, ...
- Glenmark US arm gets USFDA nod for anti-allergy tabletsPharma major Glenmark today said its US arm has received final approval from the US health regulator to market generic Levocetirizine Dihyd...
- Sun Pharma receives USFDA nod for generic Clarinex, TiazacSun Pharma has received approval from USFDA for its abbreviated new drug application to market a generic version of Schering Plough's Clari...
- Wockhardt gets USFDA tentative nod for generic rhinitis drugPharmaceutical and biotechnology firm Wockhardt today said it has received tentative approval from USFDA to sell generic version of Sanofi ...
- Ranbaxy gets USFDA approval for anti-allergic drugRanbaxy Laboratories on Friday said its US subsidiary Ranbaxy Pharmaceuticals Inc (RPI) has received tentative nod from United States Food ...
- RPI gets USFDA tentative nod for anti-allergic drugRanbaxy Laboratories on Friday said its US subsidiary Ranbaxy Pharmaceuticals Inc (RPI) has received tentative nod from United States Food ...
Load More
